Dr. Vivek N. Iyer, MD

Dr. Iyer practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Iyer's NPI, 1295812808, was assigned on November 1, 2006. Dr. Iyer holds Minnesota license 49155.

Dr. Iyer's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Iyer's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Iyer to 5 more medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Iyer practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Iyer's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Iyer is licensed in Minnesota.

CMS data shows 49 Medicare services from Dr. Iyer across 2 procedure codes in 2024, all of them office visits, for 85 Medicare patients. Medicare paid $6,590 for them.

CMS counts 85 Medicare patients who saw Dr. Iyer in 2024. The largest group is 65 to 74, with 57 patients. 62% of them have high blood pressure, and 58% have high cholesterol. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Iyer's median patient age at 69, with 61% women.

In 2024, Dr. Iyer wrote 421 Medicare Part D claims for 83 patients. 76% of them were for generic drugs. CMS names the drug for 311 of them, across 12 drugs with 11 or more claims each, at $18,371 in total drug cost. In 2023, CMS named 323 claims across 12 drugs.

Dr. Iyer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Iyer as offering telehealth.

Dmand AI links 178 papers to Dr. Iyer, published from 2010 to 2025. 2017 was the busiest year, with 15. The most frequent topics are Telangiectasia, Hereditary Hemorrhagic, Arteriovenous Malformations and Asthma. Dr. Iyer has published most often in Nat Genet. Dr. Iyer's most frequent co-authors are Vivek Iyer, MD, Hasan Ahmad Hasan Albitar, MD and Hasan Garan, MD.

Dmand AI links Dr. Iyer to 5 clinical trials. 2 are still active or recruiting. Conditions studied include Atrial Fibrillation, COVID-19 and Epistaxis. Boston Scientific Corporation sponsors the most, 2.

CMS Open Payments shows 26 general payments to Dr. Iyer from 7 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 64% of the total. Merck Sharp & Dohme Corporation paid the most, $3,857.